The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis

Spine

Volumn 34, Issue 2, 2009, Pages 115-120

  Matsudaira, Ko ^a   Seichi, Atsushi ^a   Kunogi, Junichi ^b   Yamazaki, Takashi ^c   Kobayashi, Atsuki ^b   Anamizu, Yorito ^d   Kishimoto, Junji ^e   Hoshi, Kazuto ^a   Takeshita, Katsushi ^a   Nakamura, Kozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c MUSASHINO RED CROSS HOSPITAL   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Limaprost; Lumbar spinal stenosis; Neurogenic intermittent claudication

Indexed keywords

ETODOLAC; LIMAPROST; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E1;

ADULT; AGED; ANOREXIA; ARTICLE; CAUDA EQUINA SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HOT FLUSH; HUMAN; INTERMITTENT CLAUDICATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT SATISFACTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOCIAL INTERACTION; STOMACH DISCOMFORT; STOMACH PAIN; TREATMENT OUTCOME; VERTEBRAL CANAL STENOSIS; BACKACHE; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; HYPESTHESIA; MIDDLE AGED; MULTICENTER STUDY; NEUROLOGIC DISEASE; PAIN ASSESSMENT; RADICULOPATHY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALPROSTADIL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACK PAIN; ETODOLAC; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; HYPESTHESIA; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; POLYRADICULOPATHY; SPINAL STENOSIS; TREATMENT OUTCOME;

EID: 64049112866     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31818f924d     Document Type: Article

References (30)

1. Berthelot JM, Bertrand VA, Rodet D, et al. Lumbar spinal stenosis: a review. Rev Rhum Engl Ed 1997;64:315-25.
2. Bolander NF, Schonstrom NSR, Spengler DM. Role of computed tomography and myelography in the diagnosis of central spinal stenosis. J Bone Joint Surg Am 1985;67A:240-6.
3. Takahashi K, Miyazaki T, Takino T, et al. Epidural pressure measurements; relationship between pressure and posture in patients with lumbar spinal stenosis. Spine 1995;20:650-3.
4. Yuan PS, Booth RE Jr, Albert TJ. Nonsurgical and surgical management of lumbar spinal stenosis. Instr Course Lect 2005;54:303-12.
5. Hilibrand AS, Rand N. Degenerative lumbar stenosis. J Am Acad Orthop Surg 1999;7:239-49.
6. Blau JN, Louge V. Intermittent claudication of cauda equine. Lancet 1961;1:1081-6.
7. Cavanaugh GJ, Svein J, Holman CB, et al. 'Pseudoclaudication' syndrome produced by compression of cauda equina. JAMA 1968;206:2477-81.
8. Parke WW, Watanabe R. The intrinsic vasculature of the lumbosacral spine nerve roots. Spine 1985;6:508-61.
9. Ooi Y, Mita F, Satoh Y. Myeloscopic study on lumbar spinal stenosis with special reference to intermittent claudication. Spine 1990;15:544-9.
10. Delamarter RB, Bohlam HH, Dodge LD, et al. Experimental lumbar spinal stenosis; analysis of the cortical evoked potentials, microvasculature and histopathology. J Bone Joint Surg Am 1990;72-A:110-20.
11. Olmarker K, Holm S, Rydevik B. Experimental nerve root compression. A model of acute graded compression of the porcine cauda equine and analysis of neural and vascular anatomy. Spine 1991;16:61-9.
12. Takahashi K, Olmarker K, Holm S, et al. Double level cauda equine compression: an experimental study with continuous monitoring of intraneural blood flow in the porcine cauda equine. J Orthop Res 1993;11:104-9.
13. Konno S, Sato K, Yabuki S, et al. A model for acute, chronic and delayed graded compression of the dog cauda equine; presentation of the gross, microscopic, and vascular in pressure transmission of the compression model. Spine 1995;20:2758-64.
14. Konno S, Olmarker K, Byröd G, et al. Intermittent cauda equine compression; an experimental study on the procine cauda equine with analysis of nerve impulse conduction properties. Spine 1995;20:1223-6.
15. Sato K, Yabuki S, Konno S, et al. A model for acute, chronic, and delayed graded compression of the dog cauda equine; neurophysiology and histologic change induced by acute, graded compression. Spine 1995;20:2386-91.
16. Kikuchi S, Konno S, Kayama S, et al. Increased resistance to acute compression injury in chronically compressed spinal root. Spine 1996;21:2544-50.
17. Kobayashi S, Yoshizawa H, Nakai S. Experimental study on dynamics of lumbosacral nerve root circulation. Spine 2000;25:298-305.
18. Harrison TS, Plosker GL. Limaprost. Drugs 2007;67:109-18.
19. Hatori M, Kokubun S. Clinical use of etodolac for treatment of lumbar disc herniation. Curr Med Res Opin 1999;15:193-201.
20. Arnoldi CC, Brodsky AE, Cauchoix J, et al. Lumbar spinal stenosis and nerve root entrapment: syndrome, definition, and classification. Clin Orthop 1976;115:4-5.
21. Fukuhara S, Bito S, Green J, et al. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 1998;51:1037-44.
22. Fukuhara S, Ware JE, Kosinski M, et al. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol 1998;51:1045-53.
23. Porter RW, Miller CG. Neurogenic claudication and root claudication treated with calcitonin: a double-blind trial. Spine 1988;13:1061-4.
24. Eskola A, Pohjolainen T, Alaranta H, et al. Calcitonin treatment in lumbar spinal stenosis: a randomized, placebo-controlled, double-blind, cross-over study with one-year follow-up. Calcif Tissue Int 1992;50:400-3.
25. Podichetty VK, Segal AM, Lieber M, et al. Effectiveness of salmon calcitonin nasal spray in the treatment of lumbar canal stenosis, a double-blind, randomized, placebo-controlled, parallel group trial. Spine 2004;29:2343-9.
26. Tafazal SI, Ng L, Sell P. Randomised placebo-controlled trial on the effectiveness of nasal salmon calcitonin in treatment of lumbar spinal stenosis. Eur Spine J 2007;16:207-12.
27. Yaksi A, Özgönenel L, Özgönenel B. The efficiency of gabapentin therapy in patients with lumbar spinal stenosis. Spine 2007;32:939-42.
28. Nakai K, Takenobu Y, Eguchi K, et al. Effects of OP-1206 α-CD on walking dysfunction in the rat neuropathic intermittent claudication model. Anesth Analg 2002;94:1534-41.
29. Nakai K, Takenobu Y, Takimizu H, et al. Effects of orally administered OP-1206 α-CD with loxoprofen-Na on walking dysfunction in the rat neuropathic intermittent claudication model. Prostaglandins Leukot Essent Fatty Acids 2003;69:269-73.
30. Nakai K, Takenobu Y, Takimizu H, et al. Effects of OP-1206 α-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipin, ticlopidine and cilostazol. Prostaglandins Other Lipid Mediat 2003;71:253-63.